Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration

Mov Disord. 2005 Jul;20(7):819-21. doi: 10.1002/mds.20408.

Abstract

We investigated the presence of mutations in the pantothenate kinase (PANK2) gene in a 27-year-old male Chinese patient with atypical pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Automated DNA sequence analyses revealed compound heterozygous mutations in the exon 3 and 5. This patient had a 10-year history of PKAN characterized by a slight tremor of the right hand when writing at onset and a slow progressive rigidity of the neck and the right arm and resting tremor in upper extremities. Dysarthria, dysphagia, and dystonic-athetoid movements of the face and right fingers were marked. Magnetic resonance showed the typical "eye-of-the-tiger" sign.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asian People
  • Asparagine / genetics
  • Aspartic Acid / genetics
  • DNA Mutational Analysis
  • Exons
  • Glycine / genetics
  • Heterozygote*
  • Humans
  • Isoleucine / genetics
  • Magnetic Resonance Imaging
  • Male
  • Mutation*
  • Pantothenate Kinase-Associated Neurodegeneration / genetics*
  • Pantothenate Kinase-Associated Neurodegeneration / pathology
  • Pantothenate Kinase-Associated Neurodegeneration / physiopathology
  • Phosphotransferases (Alcohol Group Acceptor) / genetics*

Substances

  • Isoleucine
  • Aspartic Acid
  • Asparagine
  • Phosphotransferases (Alcohol Group Acceptor)
  • pantothenate kinase
  • Glycine